Vijay Gore

Design of Potent, Orally Available Antagonists of the Transient Receptor Potential Vanilloid 1. Structure−Activity Relationships of 2-Piperazin-1-yl-1<i>H</i>-benzimidazoles

Vassil I. Ognyanov, Balan Chenera, Anthony W. Bannon et al. · Journal of Medicinal Chemistry · 2006 · 83 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Novel Vanilloid Receptor-1 Antagonists:  3. The Identification of a Second-Generation Clinical Candidate with Improved Physicochemical and Pharmacokinetic Properties

Huiling Wang, Jodie G. Katon, Balan Chenera et al. · Journal of Medicinal Chemistry · 2007 · 72 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

Discovery of TRPM8 Antagonist (<i>S</i>)-6-(((3-Fluoro-4-(trifluoromethoxy)phenyl)(3-fluoropyridin-2-yl)methyl)carbamoyl)nicotinic Acid (AMG 333), a Clinical Candidate for the Treatment of Migraine

Daniel B. Horne, Kaustav Biswas, James Brown et al. · Journal of Medicinal Chemistry · 2018 · 61 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +15

Fused Piperidines as a Novel Class of Potent and Orally Available Transient Receptor Potential Melastatin Type 8 (TRPM8) Antagonists

Nuria Tamayo, Yunxin Bo, Vijay Gore et al. · Journal of Medicinal Chemistry · 2012 · 55 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +15

MCC/SNAr methodology. Part 2: Novel three-step solution phase access to libraries of benzodiazepines

Paul Tempest, Liping H. Pettus, Vijay Gore et al. · Tetrahedron Letters · 2003 · 53 citations

Pharmacy, Medicinal Chemistry, Pharmacology +7